No Detail Found!

Expression of p53 and ki67 in low and high-grade non-muscle invasive papillary urothelial carcinoma

Author(s)
Nadia Hasan Department of Histopathology,,Shifa International Hospital,Islamabad,Pakistan
Zafar Ali Department of Histopathology,,Shifa International Hospital,Islamabad,Pakistan
Ambreen Moatasim Department of Histopathology,,Royal Blackburn Hospital,Blackburn, England,
Abstract
Objective: To evaluate the expression of p53 and Ki67 immunohistochemistry (IHC) as an adjunct to morphology in differentiating low and high-grade nonmuscle invasive papillary urothelial carcinomas. Methodology: This prospective cross-sectional study was carried out at Shifa International Hospital Islamabad and included 50 cases of papillary urothelial carcinoma assessed morphologically. IHC for p53 and Ki67 was performed on all cases and was analyzed using the Allred scoring system. Statistical analysis was done using Kendall's tau b test using SPSS 25. Results: Among 50 cases, 64% were males and 36% females. 62% cases were high grade, and 38% of low grade papillary urothelial carcinoma. 50% of cases were staged pTa and 50% staged pT1. Total scores (TS) for  p53 and Ki67 were high in high grade tumors while low in low grade tumors. Statistical analysis showed a significant association between proportionate score  (p:0.01) and TS (p:0.01) indices for p53 and grade of tumor. Similarly, a significant association between proportionate score (PS) (p:0.01) and TS (p:0.01) for Ki67 with grade was also found. Conclusion:  Our study concludes that p53 and Ki67 IHC can be used as an  adjunct to morphology in grading urothelial carcinomas. 
Publication Details
Page(s) 1-4
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 49, Issue: 4, Year: 2024

Request the full text from PASTIC

Keywords
grade, p53, Ki67, Papillary urothelial carcinoma
References
Bray F,Ferlay J,Soerjomataram I,Siegel RL,Torre LA,Jemal A .2018 .GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 68 : 394-424.
Mahmood S,Faraz R,Yousaf A,Quader A,Asif H,Atif A .2016 .Annual cancer registry report-2016, of the Shaukat Khanum Memorial Cancer Hospital. , : .
Mori K,D'Andrea D,Enikeev DV,Egawa S,Shariat SF .2020 .En bloc resection for nonmuscle invasive bladder cancer: review of the recent literature. Curr Opin Urol, 30 : 41-7.
Lyon .2022 .WHO classification of tumours: urinary and male genital tumours. ed. 5, 8 : .
Dobruch J,Oszczudłowski M. .2021 .Bladder cancer: current challenges and future directions. Medicina, 57 : 749-54.
Fujii Y. .2018 .Prediction models for progression of non‐muscleinvasive bladder cancer: a review. Int J Urol, 25 : 212-8.
Stec R,Cierniak S,Lubas A,Brzóskowska U,Syryło T,Zieliński H .2020 .Intensity of nuclear staining for Ki-67, p53 and surviving as a new prognostic factor in nonmuscle invasive bladder cancer. Pathol Oncol Res, 26 : 1211-9.
Thakur B,Kishore S,Dutta K,Kaushik S,Bhardwaj A .2017 .Role of p53 and Ki-67 immunomarkers in carcinoma of urinary bladder. Ind J Pathol Microbiol, 60 : 505-9.
Rodriguez Pena MD,Chaux A,Eich ML,Tregnago AC,Taheri D,Borhan W .2019 .Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder. Virchows Arch, 475 : 349-56.
Hodgson A,Xu B,Downes MR .2017 .p53 immunohistochemistry in high‐grade urothelial carcinoma of the bladder is prognostically significant. Histopathology, 71 : 296-304.
Ko K,Jeong CW,Kwak C,Kim HH,Ku JH .2017 .Significance of Ki-67 in non-muscle invasive bladder cancer patients: a systematic review and meta-analysis. Oncotarget, 8 : 100614.
Hasan A,Mohammed Y,Basiony M,Hanbazazh M,Samman A,Abdelaleem MF .2023 .Clinico-pathological features and immunohistochemical comparison of p16, p53, and Ki-67 expression in muscle-invasive and nonmuscle-invasive conventional urothelial bladder carcinoma. Clin Pract, 13 : 806-19.
Vetterlein MW,Roschinski J,Gild P,Marks P,Soave A .2017 .Impact of the Ki-67 labeling index and p53 expression status on disease-free survival in pT1 urothelial carcinoma of the bladder. Transl Androl Urol, 6 : 1018-22.
Ahmad Z,Idress R,Fatima S,Uddin N,Ahmed A,Minhas K .2016 .Commonest cancers in Pakistan-findings and histopathological perspective from a premier surgical pathology center in Pakistan. Asian Pac J Cancer Prev, 17 : 1061.
Jones TD .2021 .Histologic Grading of Bladder Tumors: Using Both the 1973 and 2004/2016 World Health Organization Systems in Combination Provides Valuable Information for Establishing Prognostic Risk Groups. Eur Urol, 79 : 489-91.
Altaf J,Mahesar MA,Jatoi T. .2017 .Clinicopathological features of bladder tumors in a single institution in Hyderabad, Sindh, Pakistan. Int J Clin Case Stud, 1 : 22-9.
Qamar S,Inam QA,Ashraf S,Khan MS,Khokhar MA,Awan N. .2017 .Prognostic value of p53 expression intensity in urothelial cancers. J Coll Physicians Surg Pak, 27 : 232-6.
Brossart DF,Laird VC,Armstrong TW .2018 .Interpreting Kendall's Tau and Tau-U for single-case experimental designs. Cogent Psychol, 5 : 1518687.
Khurshid IK,Ahmad M,Javed S,Aneeqa S,Gardezi A,Waqar M. p53,Pakistan. JIIMC M. p53 .2021 .and ki-67 expression in papillary urothelial carcinomas of urinary bladder, an experience. , 16 : 74-8.
0

Citations

0

Downloads

38

Views